Czech National Bank’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$33.5M Buy
581,252
+26,627
+5% +$1.53M 0.18% 99
2026
Q1
$33.6M Buy
554,625
+17,827
+3% +$1.04M 0.22% 82
2025
Q4
$29M Buy
536,798
+19,839
+4% +$954K 0.19% 100
2025
Q3
$23.3M Buy
516,959
+19,513
+4% +$911K 0.16% 118
2025
Q2
$23M Buy
497,446
+31,344
+7% +$1.54M 0.18% 111
2025
Q1
$28.4M Buy
466,102
+26,353
+6% +$1.54M 0.26% 82
2024
Q4
$24.9M Buy
439,749
+26,747
+6% +$1.49M 0.23% 83
2024
Q3
$21.4M Buy
413,002
+26,718
+7% +$1.25M 0.22% 94
2024
Q2
$16M Buy
386,284
+28,266
+8% +$1.26M 0.18% 109
2024
Q1
$19.4M Buy
358,018
+1,583
+0.4% +$80.6K 0.25% 83
2023
Q4
$18.3M Sell
356,435
-8,713
-2% -$457K 0.26% 81
2023
Q3
$21.2M Buy
365,148
+116,449
+47% +$7.14M 0.34% 57
2023
Q2
$15.9M Sell
248,699
-1,774
-0.7% -$119K 0.36% 53
2023
Q1
$17.4M Buy
250,473
+1,520
+0.6% +$107K 0.43% 47
2022
Q4
$17.9M Buy
248,953
+742
+0.3% +$55.9K 0.48% 42
2022
Q3
$17.6M Buy
+248,211
New +$18M 0.5% 39

Other funds holding BMY

Czech National Bank's BMY Position: Q2 2026 in Review

Czech National Bank increased its Bristol-Myers Squibb (BMY) stake by 4.8% in Q2 2026, buying an estimated $1.53M and bringing the position to 581,252 shares worth $33.5M. The position accounts for 0.18% of the portfolio, ranked #99.

Czech National Bank first reported a position in BMY in Q3 2022 and has held it in 16 quarters since. The position peaked at $33.6M in Q1 2026. 796 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Czech National Bank held 581,252 shares of Bristol-Myers Squibb worth $33.5M as of Q2 2026.
  • Czech National Bank bought 26,627 Bristol-Myers Squibb shares in Q2 2026, an estimated $1.53M.
  • Bristol-Myers Squibb made up 0.18% of Czech National Bank's portfolio in Q2 2026, its #99 holding.
  • Czech National Bank first reported a position in Bristol-Myers Squibb in Q3 2022 and has held it in 16 quarters since.
  • Czech National Bank's Bristol-Myers Squibb position peaked at $33.6M in Q1 2026.
  • 796 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Czech National Bank's 13F filing for Q2 2026, filed 8 Jul 2026.